ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,080.53
2.66%
S&P 500
5,221.42
-0.02%
Dow Jones
39,431.51
-0.21%
US Dollar vs Yen
156.2105
0.25%
Brent Oil
83.21
1.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Sangui Biotech International Inc (CE) (SGBI)

  7. Sangui Biotech International Inc (CE) (SGBI) ニュース

SGBI

Sangui Biotech (CE) (SGBI)

Sangui Biotech International Inc (CE)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:SGBI
日付受信時刻ニュースソース見出しコード企業名
2023/02/0807 : 30Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2022/11/1103 : 30Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2022/11/0405 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SGBISangui Biotech International Inc (CE)
2022/09/2905 : 12Edgar (US Regulatory)Annual Report (10-k)USOTC:SGBISangui Biotech International Inc (CE)
2022/05/1623 : 54Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2022/02/1206 : 07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2021/11/1302 : 46Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2021/09/2903 : 38Edgar (US Regulatory)Annual Report (10-k)USOTC:SGBISangui Biotech International Inc (CE)
2021/08/1401 : 42Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:SGBISangui Biotech International Inc (CE)
2021/08/1400 : 53Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:SGBISangui Biotech International Inc (CE)
2021/05/0806 : 26Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:SGBISangui Biotech International Inc (CE)
2021/05/0802 : 44Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2021/05/0101 : 28Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:SGBISangui Biotech International Inc (CE)
2020/10/0101 : 11Edgar (US Regulatory)Annual Report (10-k)USOTC:SGBISangui Biotech International Inc (CE)
2020/09/2904 : 24Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:SGBISangui Biotech International Inc (CE)
2020/08/0107 : 52Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:SGBISangui Biotech International Inc (CE)
2020/08/0107 : 44Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:SGBISangui Biotech International Inc (CE)
2020/05/1503 : 49Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2020/02/1405 : 37Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2019/11/1406 : 06Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2019/10/0905 : 29Edgar (US Regulatory)Annual Report (10-k)USOTC:SGBISangui Biotech International Inc (CE)
2019/10/0105 : 54Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:SGBISangui Biotech International Inc (CE)
2019/08/2802 : 33Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:SGBISangui Biotech International Inc (CE)
2019/08/2802 : 25Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:SGBISangui Biotech International Inc (CE)
2019/05/1404 : 24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2019/02/1407 : 23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:SGBISangui Biotech International Inc (CE)
2019/02/1407 : 21Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2018/11/1405 : 51Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:SGBISangui Biotech International Inc (CE)
2018/11/1405 : 46Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SGBISangui Biotech International Inc (CE)
2018/09/2904 : 44Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:SGBISangui Biotech International Inc (CE)
 Showing the most relevant articles for your search:USOTC:SGBI

最近閲覧した銘柄

FX
USDGBP
US Dollar vs Sterling
NYSE
NKE
Nike
AMEX
XLF
Financial Select Sector
NYSE
JPM
JP Morgan Chase
AMEX
SPY
SPDR S&P 500
SPI
SP500
S&P 500
FX
USDEUR
US Dollar vs Euro
CCOM
SILVER
SILVER
NASDAQ
MSFT
Microsoft
NYSE
BAC
Bank of America
NYSE
CVX
Chevron
PM
XAUUSD
Gold vs US Dollar
FX
USDJPY
US Dollar vs Yen
USOTC
RHHBY
Roche (QX)
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有